Skip to content
BiologicalX

Comparison

Magnesium Glycinate vs Vitamin D3 + K2

Side-by-side of Magnesium Glycinate and Vitamin D3 + K2. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.

Effects at a glance

Magnesium Glycinate

  • Shortens sleep onset latency in older adults and in deficient populations supplementing 200 to 400 mg elemental Mg
  • Improves subjective sleep quality scores (PSQI, ISI) modestly versus placebo over 4 to 8 weeks
  • Reduces nocturnal leg cramps and exercise-induced muscle cramping in some controlled trials
  • Lowers self-reported anxiety in mild-to-moderate cases, with smaller effect than first-line pharmacotherapy
  • Glycinate form delivers fewer GI side effects than oxide or citrate at equivalent elemental doses
  • Insufficient as a stand-alone hypertension treatment; small adjunctive blood-pressure reductions only

Vitamin D3 + K2

  • Reduces non-vertebral fractures 10-20% in older adults at 800 IU/day or above when combined with calcium
  • VITAL trial showed neutral results on primary CV and cancer endpoints at 2000 IU/day over 5 years
  • Vitamin D supplementation reduces respiratory infection incidence ~10-20% in deficient populations
  • K2 MK-7 has 72-hour plasma half-life vs 1-2 hours for MK-4; once-daily dosing is sufficient
  • Synergy hypothesis is largely preclinical; dedicated combination RCTs are limited
  • Daily dosing outperforms bolus dosing for immune and infection outcomes

Side-by-side

Attribute Magnesium Glycinate Vitamin D3 + K2
Category supplement supplement
Also known as magnesium bisglycinate cholecalciferol + menaquinone, D3/K2, vitamin D3 with MK-7
Half-life (hr) 5 360
Typical dose (mg) 300 0.05
Dosing frequency daily (often evening) daily with a fat-containing meal
Routes oral oral
Onset (hr) 1 24
Peak (hr) - 168
Molecular weight - 384.64
Molecular formula - C27H44O (D3); C46H64O2 (MK-7)
Mechanism Magnesium acts as a cofactor for 300+ enzymes and as a voltage-dependent antagonist at NMDA receptors; glycine serves as an inhibitory neurotransmitter and co-agonist at glycine receptors. D3 converts to calcidiol then calcitriol, activating the vitamin D receptor (VDR) to increase intestinal calcium absorption and modulate immune and bone gene transcription. K2 carboxylates osteocalcin and matrix Gla protein, directing calcium toward bone and inhibiting vascular calcification.
Legal status Dietary supplement Dietary supplement (global)
WADA status allowed allowed
DEA / Rx OTC supplement Not scheduled
Pregnancy Generally considered acceptable at RDA doses; consult clinician Recommended at standard doses for fetal bone development; consult clinician at higher doses
CAS 14783-68-7 67-97-0
PubChem CID 84645 5280795
Wikidata - Q139347

Safety profile

Magnesium Glycinate

Common side effects

  • mild GI upset at high doses
  • loose stools (dose-dependent, less than with oxide/citrate forms)

Contraindications

  • severe renal impairment
  • myasthenia gravis
  • heart block

Interactions

  • tetracycline and fluoroquinolone antibiotics: magnesium chelates antibiotic, reducing absorption; separate by 2+ hours(moderate)
  • bisphosphonates: reduced absorption of bisphosphonate(moderate)
  • potassium-sparing diuretics: possible hypermagnesemia in renal impairment(moderate)

Vitamin D3 + K2

Common side effects

  • GI upset at high doses
  • headache (rare)
  • hypercalcemia (only at sustained very high D3 doses)

Contraindications

  • hypercalcemia
  • sarcoidosis
  • active hyperparathyroidism
  • warfarin therapy (K2 component requires stable intake)

Interactions

  • warfarin: K2 component can affect anticoagulation; maintain stable intake and inform anticoagulation clinic(moderate)
  • thiazide diuretics: additive calcium retention; hypercalcemia risk with high-dose D3(moderate)
  • digoxin and calcium channel blockers: additive effects from D3-induced hypercalcemia(moderate)
  • glucocorticoids: reduced vitamin D efficacy and bone effects(moderate)
  • cholestyramine and orlistat: bind fat-soluble vitamins; separate dosing by 2 to 4 hours(moderate)

Which Should You Take?

Magnesium Glycinate and Vitamin D3 + K2 score evenly on the criteria we weight (goal breadth, legal accessibility, evidence depth). The conditionals below should drive the decision more than any aggregate score.

Edge case: Half-lives differ materially (Magnesium Glycinate ~5 hr vs Vitamin D3 + K2 ~360 hr). Vitamin D3 + K2 reaches steady state faster; Magnesium Glycinate is easier to dial in if tolerability is uncertain.

Default choice: either is defensible. Magnesium Glycinate edges out on goal breadth + legal accessibility; Vitamin D3 + K2 is the right call if your priority sits in the goals listed above.

This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.

Common questions

What is the difference between Magnesium Glycinate and Vitamin D3 + K2?

Magnesium Glycinate and Vitamin D3 + K2 differ in category (supplement vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.

Which has a longer half-life, Magnesium Glycinate or Vitamin D3 + K2?

Magnesium Glycinate half-life is 5 hours; Vitamin D3 + K2 half-life is 360 hours.

Can you stack Magnesium Glycinate with Vitamin D3 + K2?

Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.

Go deeper